- Home
- TVTX vs EQC Comparison
TVTX vs EQC Comparison
Compare TVTX & EQC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- EQC
- Stock Information
- Founded
- TVTX 2008
- EQC 1986
- Country
- TVTX United States
- EQC United States
- Employees
- TVTX N/A
- EQC 22
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- EQC Real Estate Investment Trusts
- Sector
- TVTX Health Care
- EQC Real Estate
- Exchange
- TVTX Nasdaq
- EQC Nasdaq
- Market Cap
- TVTX 1.9B
- EQC 174.6M
- IPO Year
- TVTX N/A
- EQC 1986
- Fundamental
- Price
- TVTX $17.44
- EQC $1.63
- Analyst Decision
- TVTX Strong Buy
- EQC
- Analyst Count
- TVTX 13
- EQC 0
- Target Price
- TVTX $33.08
- EQC N/A
- AVG Volume (30 Days)
- TVTX 1.5M
- EQC 676.8K
- Earning Date
- TVTX 05-05-2025
- EQC 04-30-2025
- Dividend Yield
- TVTX N/A
- EQC N/A
- EPS Growth
- TVTX N/A
- EQC N/A
- EPS
- TVTX N/A
- EQC 0.26
- Revenue
- TVTX $233,175,000.00
- EQC $57,570,000.00
- Revenue This Year
- TVTX $71.39
- EQC N/A
- Revenue Next Year
- TVTX $55.24
- EQC N/A
- P/E Ratio
- TVTX N/A
- EQC $6.10
- Revenue Growth
- TVTX 60.55
- EQC N/A
- 52 Week Low
- TVTX $5.12
- EQC $1.40
- 52 Week High
- TVTX $25.29
- EQC $21.00
- Technical
- Relative Strength Index (RSI)
- TVTX 34.91
- EQC 36.14
- Support Level
- TVTX $20.29
- EQC $1.59
- Resistance Level
- TVTX $20.98
- EQC $1.62
- Average True Range (ATR)
- TVTX 1.00
- EQC 0.02
- MACD
- TVTX -0.23
- EQC 0.03
- Stochastic Oscillator
- TVTX 2.01
- EQC 87.50
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.
About EQC Equity Commonwealth of Beneficial Interest
Equity Commonwealth is a real estate investment trust engaged in the acquisition, ownership, and operation of office buildings located throughout the United States. The vast majority of the company's real estate portfolio comprises office assets. These properties are fairly evenly dispersed between many of America's urban markets, notably Washington, Austin and Denver. Equity Commonwealth derives the vast majority of its income in the form of rental revenue from tenants occupying its offices.